Autor: "Chan EKH" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Experience and impact of stigma in people with chronic hepatitis B: a qualitative study in Asia, Europe, and the United States.
Autorzy:: Toumi M; Aix-Marseille University, Jardin du Pharo, 58 bd Charles Livon, Marseille, 13284 Cedex 07, France. .; Department of Public Health, Aix-Marseille University, 27 Boulevard Jean Moulin, Marseille, 13385, France. .
Wallace J; Burnet Institute, 85 Commercial Rd, Melbourne, VIC, 3004, Australia.
Cohen C; Hepatitis B Foundation, 3805 Old Easton Rd, Doylestown, PA, 18902, USA.
Marshall C; Clarivate (formerly DRG Abacus), 70 St Mary Axe, London, EC3A 8BE, UK.
Kitchen H; Clarivate (formerly DRG Abacus), 70 St Mary Axe, London, EC3A 8BE, UK.
Macey J; Clarivate (formerly DRG Abacus), 70 St Mary Axe, London, EC3A 8BE, UK.
Pegram H; Clarivate (formerly DRG Abacus), 70 St Mary Axe, London, EC3A 8BE, UK.
Slagle AF; Aspen Consulting, LLC, 625 S Lincoln Ave #101, Steamboat Springs, CO, 80487, USA.
Gish RG; Hepatitis B Foundation, 3805 Old Easton Rd, Doylestown, PA, 18902, USA.
Ning Q; Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie Fang Avenue, Hankou, Wuhan, 430030, China.
Yatsuhashi H; National Hospital Organization (NHO) Nagasaki Medical Center, 2-1001-1, Kubara, Omura, Nagasaki, 856-8562, Japan.; Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki City, 852-8520, Japan.
Cornberg M; Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Brunetto M; University Hospital of Pisa, Lungarno Pacinotti 43, Pisa, 56126, Italy.
van Bömmel F; Division of Hepatology, Department of Medicine II, Leipzig University Medical Center, Liebigstrasse 20, 04103, Leipzig, Germany.
Xie Q; Shanghai Jiao Tong University School of Medicine, Ruijin Hospital, 227 South Chongqing Road, Shanghai, 20025, China.
Lee D; Inno Community Development Organisation, Room 208, Dengzheng Business Center, #57, Dengzhengnan Rd, Yuexiu District, Guangzhou, Guangdong, China.
Habuka N; Janssen Pharmaceutical K.K, 3-5-2 Nishi-kanda, Chiyoda-ku, Tokyo, 101-0065, Japan.
Sbarigia U; Janssen Pharmaceutica NV, Turnhoutseweg 30, Beerse, B-2340, Belgium.
Beumont-Mauviel M; Janssen Research & Development, LLC, 1125 Trenton Harbourton Rd, Titusville, NJ, 08560, USA.
Keever AV; Janssen Research & Development, 1400 McKeon Road, Spring House, PA, 19002, USA.
Takahashi Y; Janssen Pharmaceutical K.K, 3-5-2 Nishi-kanda, Chiyoda-ku, Tokyo, 101-0065, Japan.
Lu Y; Janssen China, 14F, Tower 3, China Central Place, No.77, Jian Guo Road, Chaoyang District, Beijing, 100025, China.
Liu A; Janssen China, 14F, Tower 3, China Central Place, No.77, Jian Guo Road, Chaoyang District, Beijing, 100025, China.
Chen Q; Janssen China, 14F, Tower 3, China Central Place, No.77, Jian Guo Road, Chaoyang District, Beijing, 100025, China.
Ito T; Janssen Health Economics & Market Access (EMEA), 50-100 Holmers Farm Way, High Wycombe, Buckinghamshire, HP12 4EG, UK.
Radunz O; Janssen Germany, Johnson-u.-Johnson-Platz 1, 41470, Neuss, Nordrhein-Westfalen, Germany.
Puggina A; Janssen Italy, Via Michelangelo Buonarroti, 23, Cologno Monzese, 20093, Italy.
Hilgard G; Janssen Germany, Johnson-u.-Johnson-Platz 1, 41470, Neuss, Nordrhein-Westfalen, Germany.
Chan EKH; Janssen Global Services, LLC, 1000 US 202, Raritan, NJ, 08869, USA. .
Wang S; Hepatitis B Foundation, 3805 Old Easton Rd, Doylestown, PA, 18902, USA.; Cooperman Barnabas Medical Center, 222 Columbia Turnpike, Florham Park, NJ, 07932, USA.; Pokaż więcej
Źródło:: BMC public health [BMC Public Health] 2024 Feb 26; Vol. 24 (1), pp. 611. Date of Electronic Publication: 2024 Feb 26.
Typ publikacji:: Journal Article
MeSH Terms:: Hepatitis B, Chronic*/psychology
Hepatitis B*/psychology
Adult ; Humans ; United States/epidemiology ; Quality of Life ; Social Stigma ; Asia ; Europe

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Effect of Intravenous Golimumab on Fatigue and the Relationship with Clinical Response in Adults with Active Ankylosing Spondylitis in the Phase 3 GO-ALIVE Study.
Autorzy:: Deodhar A; Division of Arthritis and Rheumatic Diseases (OP09), Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR, 97239, USA. .
Shiff NJ; Janssen Scientific Affairs, LLC, Immunology, 800 Ridgeview Dr, Horsham, PA, 19044, USA.; Department of Community Health and Epidemiology, Adjunct, College of Medicine, University of Saskatchewan, Saskatoon, Canada.
Gong C; Janssen Scientific Affairs, LLC, Immunology, 800 Ridgeview Dr, Horsham, PA, 19044, USA.
Chan EKH; Janssen Global Services, LLC, 1000 US Route 202 South, Raritan, NJ, 08869, USA.
Hsia EC; Janssen Research & Development, LLC, Immunology, 1400 McKean Rd, Spring House, PA, 19477, USA.; University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
Lo KH; Janssen Research & Development, LLC, Immunology, 1400 McKean Rd, Spring House, PA, 19477, USA.
Akawung A; Janssen Research & Development, LLC, Immunology, 1400 McKean Rd, Spring House, PA, 19477, USA.
Kim L; Janssen Research & Development, LLC, Immunology, 1400 McKean Rd, Spring House, PA, 19477, USA.
Xu S; Janssen Research & Development, LLC, Immunology, 1400 McKean Rd, Spring House, PA, 19477, USA.
Reveille JD; University of Texas McGovern Medical School, 6431 Fannin St, Houston, TX, 77030, USA.; Pokaż więcej
Źródło:: Rheumatology and therapy [Rheumatol Ther] 2023 Aug; Vol. 10 (4), pp. 983-999. Date of Electronic Publication: 2023 Jun 15.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Clinical Outcomes and Quantitative HBV Surface Antigen Levels in Diverse Chronic Hepatitis B Patients in Canada: A Retrospective Real-World Study of CHB in Canada (REVEAL-CANADA).
Autorzy:: Coffin CS; Cumming School of Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada.
Haylock-Jacobs S; Cumming School of Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada.
Doucette K; Department of Medicine, University of Alberta, Edmonton, AB T6G 2R3, Canada.
Ramji A; Department of Medicine, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
Ko HH; Department of Medicine, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
Wong DK; Department of Medicine, University of Toronto, Toronto, ON M5G 2CV, Canada.
Elkhashab M; Toronto Liver Centre, Toronto, ON M6H 3M1, Canada.
Bailey R; Bailey Health Clinic, Edmonton, AB T5H 4B9, Canada.
Uhanova J; Department of Internal Medicine, University of Manitoba, Winnipeg, MB R3T 2N2, Canada.
Minuk G; Department of Internal Medicine, University of Manitoba, Winnipeg, MB R3T 2N2, Canada.
Tsoi K; Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada.
Wong A; Department of Medicine, University of Saskatchewan, Regina, SK S7N 5A2, Canada.
Ma MM; Department of Medicine, University of Alberta, Edmonton, AB T6G 2R3, Canada.
Tam E; Pacific Gastroenterology Associates, Vancouver, BC V6Z 2K5, Canada.
Brahmania M; Multi Organ Transplant Unit, Department of Medicine, Division of Gastroenterology, Western University, London, ON N6A 3K7, Canada.
Nudo C; Cité-de-la-Santé de Laval, Laval, QC H7M 3L9, Canada.
Zhu J; Faculty of Medicine, Dalhousie University, Halifax, NS B3H 4R2, Canada.
Lowe CF; Division of Medical Microbiology, Providence Health Care, Vancouver, BC V6Z 1Y6, Canada.
Osiowy C; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada.
Lethebe BC; Cumming School of Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada.
Congly SE; Cumming School of Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada.
Chan EKH; Janssen Global Services LC, Raritan, NJ 08869, USA.
Villasis-Keever A; Janssen Global Services LC, Raritan, NJ 08869, USA.
Sbarigia U; Janssen Pharmaceuticals NV, 2340 Beerse, Belgium.
Cooper CL; Department of Medicine, Division of infectious Diseases, University of Ottawa, Ottawa, ON K1N 6N5, Canada.
Fung S; Department of Medicine, University of Toronto, Toronto, ON M5G 2CV, Canada.; Pokaż więcej
Źródło:: Viruses [Viruses] 2022 Nov 29; Vol. 14 (12). Date of Electronic Publication: 2022 Nov 29.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Hepatitis B, Chronic*
Carcinoma, Hepatocellular*/drug therapy
Liver Neoplasms*/drug therapy
Adult ; Humans ; Female ; Middle Aged ; Male ; Hepatitis B Surface Antigens ; Hepatitis B virus/genetics ; Retrospective Studies ; Hepatitis B e Antigens ; Antigens, Surface ; Cohort Studies ; Cross-Sectional Studies ; Canada/epidemiology ; Antiviral Agents/therapeutic use ; Liver Cirrhosis/diagnosis ; Liver Cirrhosis/drug therapy ; Liver Cirrhosis/complications ; DNA, Viral

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Implementing patient-reported outcome measures in clinical practice: a companion guide to the ISOQOL user's guide.
Autorzy:: Chan EKH; Measurement, Evaluation, and Research Methodology (MERM) Program, University of British Columbia, 2125 Main Mall, Vancouver, BC, V6T 1Z4, Canada.; Janssen Global Services, LLC, Raritan, NJ, 08869, USA.
Edwards TC; Department of Health Services, University of Washington, 4333 Brooklyn Ave NE, Seattle, WA, 98195-9455, USA.
Haywood K; Warwick Research in Nursing, Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK.
Mikles SP; Department of Biomedical Informatics and Medical Education, University of Washington, 1959 NE Pacific Street, Box 357240, Seattle, WA, 98195, USA.
Newton L; Clinical Outcomes Solutions, Unit 68, Folkestone Enterprise Centre, Shearway Business Park, Shearway Road, Folkestone, Kent, CT19 4RH, UK. .; Pokaż więcej
Źródło:: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2019 Mar; Vol. 28 (3), pp. 621-627. Date of Electronic Publication: 2018 Nov 17.
Typ publikacji:: Journal Article
MeSH Terms:: Guidelines as Topic*
Patient Reported Outcome Measures*
Practice Patterns, Physicians'*
Quality of Life*
Canada ; Consensus ; Denmark ; England ; Health Personnel ; Humans ; Netherlands ; Surveys and Questionnaires ; United States

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Improvement of fatigue, physical functioning, and well-being among patients with severe impairment at baseline receiving ibrutinib in combination with bendamustine and rituximab for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma in the HELIOS study.
Autorzy:: Cramer P; a Department I of Internal Medicine and Center of Integrated Oncology Cologne-Bonn , German CLL Study Group, University Hospital Cologne , Cologne , Germany.
Fraser G; b Juravinski Cancer Centre, McMaster University , Hamilton , ON , Canada.
Santucci-Silva R; c Hemomed Oncologia e Hematologia, IEP São Lucas , São Paulo , Brazil.
Grosicki S; d Silesian Medical University , Katowice , Poland.
Dilhuydy MS; e Hôpital Haut-Lévêque , Pessac , France.
Janssens A; f Universitaire Ziekenhuizen Leuven , Leuven , Belgium.
Loscertales J; g Hematology Department , Hospital Universitario La Princesa, IIS-IP , Madrid , Spain.
Rule S; h Plymouth University Medical School , Plymouth , UK.
Goy A; i John Theurer Cancer Center at Hackensack University Medical Center , Hackensack , NJ , USA.
Traina S; j Janssen Global Services , Raritan , NJ , USA.
Chan EKH; j Janssen Global Services , Raritan , NJ , USA.
Diels J; k Janssen EU HEMAR Statistics & Modelling , Beerse , Belgium.
Sengupta N; l Janssen Global Oncology , Raritan , NJ , USA.
Mahler M; j Janssen Global Services , Raritan , NJ , USA.
Salman M; j Janssen Global Services , Raritan , NJ , USA.
Howes A; m Janssen Research & Development , High Wycombe , UK.
Chanan-Khan A; n Mayo Clinic Cancer Center , Jacksonville , FL , USA.; Pokaż więcej
Źródło:: Leukemia & lymphoma [Leuk Lymphoma] 2018 Sep; Vol. 59 (9), pp. 2075-2084. Date of Electronic Publication: 2018 Jan 03.
Typ publikacji:: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:: Physical Fitness*
Quality of Life*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Fatigue/*prevention & control
Leukemia, Lymphocytic, Chronic, B-Cell/*drug therapy
Adenine/analogs & derivatives ; Aged ; Bendamustine Hydrochloride/administration & dosage ; Double-Blind Method ; Fatigue/physiopathology ; Female ; Humans ; Leukemia, Lymphocytic, Chronic, B-Cell/pathology ; Leukemia, Lymphocytic, Chronic, B-Cell/physiopathology ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; Outcome Assessment, Health Care/methods ; Outcome Assessment, Health Care/statistics & numerical data ; Piperidines ; Pyrazoles/administration & dosage ; Pyrimidines/administration & dosage ; Rituximab/administration & dosage ; Surveys and Questionnaires

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Chan EKH"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język